NYSEAMERICAN:VTAK Catheter Precision Q3 2026 Earnings Results & Report $0.15 0.00 (0.00%) As of 10/9/2026 Catheter Precision beat analyst earnings expectations but missed on revenue in its Q3 2026 results, released November 16, 2026. The company reported EPS of -$8.16 versus the -$13.30 consensus estimate, while revenue of $1.84 million fell short of the $2.80 million estimate by $962.00 thousand. Research:ProfileEarnings History Earnings Announcement Details QuarterQ3 2026Report DateNovember 16, 2026TimeBefore Market Opens Catheter Precision EPS ResultsActual EPS-$8.16Consensus EPS -$13.30Beat/MissBeat by +$5.14One Year Ago EPSN/ACatheter Precision Revenue ResultsActual Revenue$1.84 millionExpected Revenue$2.80 millionBeat/MissMissed by -$962.00 thousandYoY Revenue GrowthN/AConference Call ResourcesEarnings HistoryCompany Profile Catheter Precision Q3 2026 Earnings FAQ Did Catheter Precision beat earnings estimates for Q3 2026? Catheter Precision (NYSEAMERICAN:VTAK) reported earnings of -$8.16 per share for Q3 2026, beating the consensus estimate of -$13.30. The report was announced on Monday, November 16, 2026. What was Catheter Precision's revenue for Q3 2026? Catheter Precision reported revenue of $1.84 million for Q3 2026, against a consensus estimate of $2.80 million. Catheter Precision Earnings HeadlinesCatheter Precision Announces New FDA 510(k) Clearance for its VIVO System, Enabling Use in a Broader Patient PopulationNovember 2, 2026 | marketscreener.comMFlyte Aviation Rebrands and Executes Reverse Stock SplitOctober 5, 2026 | tipranks.comWorse than socialismDonald Trump and Bernie Sanders rarely agree on anything, yet both are steering the country toward the same economic system, according to veteran analyst Porter Stansberry. The government has already taken stakes in companies like Intel, Lithium Americas, and MP Materials, while political rhetoric on both sides points toward deeper centralization. Stansberry has spent months investigating what this bipartisan shift could mean for investors navigating the months ahead.November 20 at 1:00 AM | Porter & Company (Ad)Flyte Aviation Launches Under NYSE American Ticker “VJET”October 5, 2026 | globenewswire.comCatheter Precision, Inc. will Change its Ticker to VJET from VTAKOctober 4, 2026 | marketscreener.comMCatheter Precision to rebrand as Flyte Aviation, adopt VJET tickerOctober 2, 2026 | msn.comSee More Catheter Precision Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Catheter Precision? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Catheter Precision and other key companies, straight to your email. Email Address About Catheter PrecisionCatheter Precision (NYSEAMERICAN:VTAK) is a medical technology company focused on products for electrophysiology, the specialty concerned with diagnosing and treating abnormal heart rhythms. Its products are designed to support clinicians during procedures involving cardiac arrhythmias.The company’s VIVO system uses patient-specific imaging and electrical data to create a three-dimensional view of the heart and help clinicians locate the source of ventricular arrhythmias before ablation procedures. Catheter Precision also offers LockeT, a device intended to assist with closure of femoral venous access sites after procedures.Catheter Precision’s product portfolio reflects its focus on tools for planning and supporting electrophysiology procedures. Its shares trade on the NYSE American under the symbol VTAK.View Catheter Precision ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting GameWalmart Earnings Change the Narrative as Digital Growth Lifts OutlookWhatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play ItLowe's Earnings Beat Looked Strong Until a 34-Cent Tariff Refund Changed the MathApple's Next Margin Defense Could Be Hiding in Your WalletThe Uranium Price Paradox: 5 Investments Facing Very Different Tests in 2027Target Stock Is Up Over 70%—Has the Easy Money Already Been Made? Upcoming Earnings Hewlett Packard Enterprise (11/23/2026)Medtronic (11/24/2026)Analog Devices (11/24/2026)Autodesk (11/24/2026)Dell Technologies (11/24/2026)Deere & Company (11/25/2026)CrowdStrike (12/1/2026)Marvell Technology (12/1/2026)Bank Of Montreal (12/2/2026)Bank of Nova Scotia (12/2/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.